Abstract
Blood transfusion medicine requires a constant supply of platelets, which is now totally donor dependent. Recent advances in the generation of platelets in vitro through megakaryocytes (MKs) may provide protocols not only via pluripotent stem cells, including induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), but also via induced MKs (iMKs). For the first time, mouse and human fibroblasts are successfully transdifferentiated into iMKs by the introduction of three factors, p45NF-E2, Maf G, and Maf K.
Original language | English (US) |
---|---|
Pages (from-to) | 176-178 |
Number of pages | 3 |
Journal | Cell research |
Volume | 23 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2013 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Biology
- Cell Biology